Koshinski Asset Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-4,454
| Closed | -$276K | – | 709 |
|
2022
Q1 | $276K | Sell |
4,454
-134
| -3% | -$8.31K | 0.02% | 496 |
|
2021
Q4 | $372K | Buy |
4,588
+103
| +2% | +$8.36K | 0.03% | 469 |
|
2021
Q3 | $426K | Buy |
4,485
+38
| +0.9% | +$3.61K | 0.04% | 417 |
|
2021
Q2 | $438K | Sell |
4,447
-138
| -3% | -$13.6K | 0.06% | 355 |
|
2021
Q1 | $383K | Sell |
4,585
-111
| -2% | -$9.27K | 0.04% | 415 |
|
2020
Q4 | $405K | Sell |
4,696
-245
| -5% | -$21.1K | 0.05% | 368 |
|
2020
Q3 | $388 | Sell |
4,941
-47
| -0.9% | -$4 | 0.05% | 346 |
|
2020
Q2 | $362K | Sell |
4,988
-569
| -10% | -$41.3K | 0.06% | 346 |
|
2020
Q1 | $257K | Hold |
5,557
| – | – | 0.05% | 374 |
|
2019
Q4 | $340K | Buy |
+5,557
| New | +$340K | 0.06% | 386 |
|
2019
Q3 | – | Sell |
-5,077
| Closed | -$263K | – | 159 |
|
2019
Q2 | $263K | Buy |
5,077
+490
| +11% | +$25.4K | 0.11% | 221 |
|
2019
Q1 | $254 | Buy |
+4,587
| New | +$254 | 0.07% | 321 |
|
2018
Q4 | – | Sell |
-5,343
| Closed | -$372K | – | 415 |
|
2018
Q3 | $372K | Buy |
5,343
+1,420
| +36% | +$98.9K | 0.05% | 380 |
|
2018
Q2 | $224K | Sell |
3,923
-109
| -3% | -$6.22K | 0.07% | 342 |
|
2018
Q1 | $222K | Sell |
4,032
-1,100
| -21% | -$60.6K | 0.07% | 329 |
|
2017
Q4 | $288K | Sell |
5,132
-1,944
| -27% | -$109K | 0.07% | 345 |
|
2017
Q3 | $433K | Buy |
7,076
+213
| +3% | +$13K | 0.14% | 223 |
|
2017
Q2 | $366K | Hold |
6,863
| – | – | 0.13% | 233 |
|
2017
Q1 | $331K | Buy |
6,863
+47
| +0.7% | +$2.27K | 0.13% | 226 |
|
2016
Q4 | $272K | Sell |
6,816
-386
| -5% | -$15.4K | 0.13% | 228 |
|
2016
Q3 | $349K | Buy |
+7,202
| New | +$349K | 0.17% | 188 |
|
2016
Q1 | – | Sell |
-4,204
| Closed | -$301K | – | 224 |
|
2015
Q4 | $301K | Buy |
4,204
+188
| +5% | +$13.5K | 0.21% | 144 |
|
2015
Q3 | $363K | Sell |
4,016
-1,011
| -20% | -$91.4K | 0.23% | 138 |
|
2015
Q2 | $454K | Buy |
5,027
+25
| +0.5% | +$2.26K | 0.29% | 105 |
|
2015
Q1 | $396K | Buy |
5,002
+20
| +0.4% | +$1.58K | 0.26% | 116 |
|
2014
Q4 | $313K | Buy |
+4,982
| New | +$313K | 0.18% | 158 |
|